Cargando…
Expression of estrogen receptor beta in the breast carcinoma of BRCA1 mutation carriers
BACKGROUND: Breast cancers (BC) in women carrying mutations in BRCA1 gene are more frequently estrogen receptor negative than the nonhereditary BC. Nevertheless, tamoxifen has been found to have a protective effect in preventing contralateral tumors in BRCA1 mutation carriers. The identification of...
Autores principales: | Litwiniuk, Maria M, Rożnowski, Krzysztof, Filas, Violetta, Godlewski, Dariusz D, Stawicka, Małgorzata, Kaleta, Remigiusz, Bręborowicz, Jan |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2387169/ https://www.ncbi.nlm.nih.gov/pubmed/18405391 http://dx.doi.org/10.1186/1471-2407-8-100 |
Ejemplares similares
-
Estrogen Receptor Status Oppositely Modifies Breast Cancer Prognosis in BRCA1/BRCA2 Mutation Carriers Versus Non-Carriers
por: Vocka, Michal, et al.
Publicado: (2019) -
Are estrogen receptor-positive breast cancers in BRCA1 mutation carriers sporadic?
por: Lakhani, Sunil R, et al.
Publicado: (2010) -
DNA stabilization by the upregulation of estrogen signaling in BRCA gene mutation carriers
por: Suba, Zsuzsanna
Publicado: (2015) -
POTENTIAL CONSEQUENCES OF THE BRCA1 MUTATION CARRIER STATE ON ESTROGEN RESPONSIVE ORGANS
por: Yen, Hai-Yun, et al.
Publicado: (2012) -
Estrogen receptor-positive breast cancer and adverse outcome in BRCA2 mutation carriers and young non-carrier patients
por: Vidarsdottir, Linda, et al.
Publicado: (2023)